Table 2 Distribution of in-bore biopsy targets to the prostate sectors.
From: Imaging of clinically silent rectoprostatic hematoma in MRI guided in-bore prostate biopsy
Prostate sector | All targets n (%) | Targets in patients with rectoprostatic hematoma n (%) |
---|---|---|
Basal TZa | 14 (1.4) | 0 (0) |
Middle TZa | 49 (4.8) | 2 (2.4) |
Apical TZa | 20 (2.0 | 1 (1.2) |
Basal TZp | 60 (5.9) | 3 (3.6) |
Middle TZp | 105 (10.3) | 11 (13.3) |
Apical TZp | 65 (6.4) | 4 (4.8) |
Basal PZa | 6 (0.6) | 0 (0) |
Middle PZa | 7 (0.7) | 0 (0) |
Apical PZa | 7 (0.7) | 0 (0) |
Basal PZpm | 56 (5.5) | 8 (9.6) |
Middle PZpm | 203 (20.0) | 17 (20.5) |
Apical PZpm | 108 (10.6) | 12 (14.5) |
Basal PZpl | 35 (3.4) | 3 (3.6) |
Middle PZpl | 144 (14.2) | 16 (19.3) |
Apical PZpl | 136 (13.4) | 6 (7.2) |